publicações selecionadas
- A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters
- Two-photon microscopy analysis reveals different pulmonary damage after infection by influenza or SARS-CoV-2
- Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy
- Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
- SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance
- COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters
- Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein
- Irreversible inhibitors of the proline racemase unveil innovative mechanism of action as antibacterial agents against
- Avaliação da expressão gênica de citocinas no encéfalo de cães com leishmaniose visceral
- Expressão gênica de citocinas no encéfalo de cães com leishmaniose visceral
- Bone marrow fat, visceral fat and body condition as parameters of possible neglect in dogs with visceral leishmaniasis
- Neuropatogenia da leishmaniose visceral canina: investigação de mediadores inflamatórios
- Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein
- Neuropatogenia da leishmaniose visceral canina: Investigação de mediadores inflamatórios
- A combination of two human monoclonal antibodies cures symptomatic rabies
- Nouveaux aspects de la lutte contre la rage
- Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody
- Intrathecal Transplantation of Autologous and Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Dogs
- Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin
- Prodrugs as new therapies against Chagas disease: in vivo synergy between Trypanosoma cruzi proline racemase inhibitors and benznidazole
- Imprinted antibody responses against SARS-CoV-2 Omicron sublineages